| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |